Tobias Huber University Medical Center Hamburg-EppendorfGermany

Tobias B. Huber is Chair of the Center of Internal Medicine and Director of the III. Department of Medicine (Nephrology, Rheumatology, Endocrinology and Transplantation) at the University Medical Center Hamburg-Eppendorf (UKE). Tobias B. Together with his team he has been recognized for discovering signalling pathways relevant for kidney development, filtration, maintenance and disease. He received numerous national and international recognitions including the Donald W. Seldin Young Investigator Award of the American Society of Nephrology and is elected member of the American Society of Clinical Investigation and the Association of American Physicians.

2 APRIL 2023

Time	Session

10:30 11:30	Plenary Session 4: Rapid COVID-19 Vaccine Development and the Future of Pandemic Preparedness Agnes B. Fogo Chairperson agnes.fogo@vanderbilt.eduVanderbilt University Medical CenterUnited States Masaomi Nangaku Chairperson mnangaku@m.u-tokyo.ac.jpthe University of Tokyo Graduate School of MedicineJapan Introduction of Plenary Speaker Rapid COVID-19 Vaccine Development and the Future of Pandemic Preparedness Barney Graham Speaker Plenary bgraham@msm.eduMorehouse School of MedicineUnited States Discussion Matthias Kretzler Speaker kretzler@umich.eduUniversity Of Michigan Medical CenterUnited States Sarinya Boongird Speaker sarinya.bon@mahidol.ac.thDivision of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityThailand Tobias Huber Speaker t.huber@uke.deUniversity Medical Center Hamburg-EppendorfGermany Introduction of Schrier Award Acceptance Speech by Awardee (Schrier Award) Irma Tchokhonelidze Speaker irma.tchokhonelidze@gmail.comTbilisi State Medical University and High Medical Technology University ClinicGeorgia Message from Outgoing ISN President Agnes B. Fogo Speaker agnes.fogo@vanderbilt.eduVanderbilt University Medical CenterUnited States Message from Incoming ISN President Masaomi Nangaku Speaker mnangaku@m.u-tokyo.ac.jpthe University of Tokyo Graduate School of MedicineJapan Plenary Halls 2 & 3

Time

Session

10:30

11:30

Plenary Session 4: Rapid COVID-19 Vaccine Development and the Future of Pandemic Preparedness

Agnes B. Fogo Chairperson agnes.fogo@vanderbilt.eduVanderbilt University Medical CenterUnited States

Masaomi Nangaku Chairperson mnangaku@m.u-tokyo.ac.jpthe University of Tokyo Graduate School of MedicineJapan

Introduction of Plenary Speaker
Rapid COVID-19 Vaccine Development and the Future of Pandemic Preparedness

Barney Graham Speaker Plenary bgraham@msm.eduMorehouse School of MedicineUnited States
Discussion

Matthias Kretzler Speaker kretzler@umich.eduUniversity Of Michigan Medical CenterUnited States

Sarinya Boongird Speaker sarinya.bon@mahidol.ac.thDivision of Nephrology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol UniversityThailand

Tobias Huber Speaker t.huber@uke.deUniversity Medical Center Hamburg-EppendorfGermany
Introduction of Schrier Award
Acceptance Speech by Awardee (Schrier Award)

Irma Tchokhonelidze Speaker irma.tchokhonelidze@gmail.comTbilisi State Medical University and High Medical Technology University ClinicGeorgia
Message from Outgoing ISN President

Agnes B. Fogo Speaker agnes.fogo@vanderbilt.eduVanderbilt University Medical CenterUnited States
Message from Incoming ISN President

Masaomi Nangaku Speaker mnangaku@m.u-tokyo.ac.jpthe University of Tokyo Graduate School of MedicineJapan

Plenary Halls 2 & 3

31 MARCH 2023

Time	Session

08:30 10:00	Update on CKD Epidemiology. ISN-KSN Joint Session Sang Youb Han Chairperson hansy@paik.ac.krInje UniversitySouth Korea Hyeong Cheon Park Chairperson amp97nody@gmail.comGangnam Severance Hospital, Yonsei University College of MedicineSouth Korea Epidemiology of CKD Jonathan Craig Speaker jonathan.craig@flinders.edu.auFlinders UniversityAustralia SARS-CoV-2 and the implications for CKD Tobias Huber Speaker t.huber@uke.deUniversity Medical Center Hamburg-EppendorfGermany Gender Disparity in Kidney Transplantation Curie Ahn Speaker curieoffice@gmail.comNational Medical CenterSouth Korea CKD Prevalence and Supports in LMIC and LIC Surasak Kantachuvesiri Speaker surasak.kan@mahidol.ac.thNephrology DivisionThailand Q and A Plenary Hall 1
11:45 12:45	Hot Debate on SGLT2i: Metabolic versus Hemodynamic Effects Sinee Disthabanchong Chairperson sineemd@hotmail.comFaculty of Medicine, Ramathibodi Hospital, Mahidol UniversityThailand Tobias Huber Chairperson t.huber@uke.deUniversity Medical Center Hamburg-EppendorfGermany Hemodynamic Effects David Cherney Speaker david.cherney@uhn.on.caToronto General HospitalCanada Metabolic Effects Chuan-Ming Hao Speaker chuanminghao@fudan.edu.cnHuashan Hospital Fudan UniversityChina Opening Remarks by Session Chairs Speakers' Discussion Q and A Closing Remarks by Speakers Audience Voting Plenary Halls 2 & 3